XML 28 R17.htm IDEA: XBRL DOCUMENT v3.25.3
Identifiable Intangible Assets, Net and Goodwill
 9 Months Ended
Sep. 28, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Identifiable Intangible Assets, Net and Goodwill Identifiable Intangible Assets, Net and Goodwill
A. Identifiable Intangible Assets
The following summarizes the components of Identifiable intangible assets:
September 28, 2025December 31, 2024
(MILLIONS)Gross
Carrying
Amount		Accumulated
Amortization
Identifiable
Intangible
Assets, Net
Gross
Carrying
Amount		Accumulated
Amortization
Identifiable
Intangible
Assets, Net
Finite-lived intangible assets
Developed technology rights(a)
$101,220 $(69,057)$32,163 $99,397 $(65,044)$34,353 
Brands
1,274 (1,023)251 1,277 (992)285 
Licensing agreements and other2,355 (1,256)1,099 2,724 (1,513)1,210 
104,849 (71,337)33,513 103,397 (67,549)35,848 
Indefinite-lived intangible assets
IPR&D(a), (b)
17,350 17,350 18,893 18,893 
Licensing agreements and other(c)
461 461 670 670 
17,811 17,811 19,563 19,563 
Identifiable intangible assets(d)
$122,660 $(71,337)$51,324 $122,961 $(67,549)$55,411 
(a)The changes in the gross carrying amounts primarily reflect the transfer of $600 million and $590 million from IPR&D to developed technology rights for Padcev and talazoparib (Talzenna), respectively, as well as the impact of foreign exchange.
(b)The decrease in the gross carrying amount reflects an impairment of $260 million (see Note 4).
(c)The decrease in the gross carrying amount reflects an impairment of $210 million (see Note 4).
(d)The decrease is primarily due to amortization expense of $3.6 billion.
B. Goodwill
As a result of the organizational changes to the commercial structure within the Biopharma operating segment effective in the first quarter of 2025 (see Note 13A), our goodwill was reallocated among impacted reporting units. We completed the re-allocation during the first quarter of 2025 and concluded that none of our goodwill was impaired. All goodwill continues to be assigned within the Biopharma reportable segment.